Themis is a Pharmaceuticals company based at 11-2 FN 333359 i, Vienna, Vienna, AT founded in Jan. 1, 2009, midnight.
| Website | http://www.themisbio.com |
| Revenue | $13 million |
| Funding | $66.4 million |
| Employees | 17 (17 on RocketReach) |
| Founded | 2009 |
| Address | 11-2 FN 333359 i, Vienna, Vienna, AT |
| Phone | +1 431-236-7151 |
| Industry | Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research |
| Web Rank | 8 Million |
| Keywords | Themis Bioscience, Themis Chikungunya Vaccine, Themis Vienna, Themis Pharmaceuticals, Fischer Biotech |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, MilliporeSigma, Bio-Rad Laboratories, QIAGEN, Promega Corporation, Cell Signaling Technology (CST), Takara Bio USA, Inc. +41 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Themis employee's phone or email?
The Themis annual revenue was $13 million in 2026.
17 people are employed at Themis.
Themis is based in Vienna, Vienna.
The NAICS codes for Themis are [3254, 325, 32541, 32].
The SIC codes for Themis are [2834, 28, 283].